The results showed that the relevant pathways of SQYSF in the treatment of CKD include Tyrosine metabolism, Calcium signaling pathway, mTOR signaling pathway, AMPK signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Toll-like receptor signaling pathway, HIF-1 signaling pathway. Here, MTOR is linked to chronic kidney disease.